BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29238287)

  • 1. Survey among ESGE members on leiomyosarcoma morcellation incidence.
    Tanos V; Brölmann H; DeWilde RL; O'Donovan P; Symeonidou E; Campo R
    Gynecol Surg; 2017; 14(1):25. PubMed ID: 29238287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
    Lieng M; Berner E; Busund B
    J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Leiomyosarcoma at Surgery for Presumed Uterine Myomas in Different Age Groups.
    Rey Valzacchi GM; Rosas P; Uzal M; Gil SJ; Viglierchio VT
    J Minim Invasive Gynecol; 2020; 27(4):926-929. PubMed ID: 31260748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic Power Morcellation: Techniques to Avoid Tumoral Spread.
    Zapardiel I; Boria F; Halaska MJ; De Santiago J
    J Minim Invasive Gynecol; 2021 Aug; 28(8):1442-1443. PubMed ID: 32961359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-bag manual versus uncontained power morcellation for laparoscopic myomectomy.
    Zullo F; Venturella R; Raffone A; Saccone G
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013352. PubMed ID: 32374421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma.
    Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A
    J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of occult leiomyosarcoma in presumed morcellation cases: a database study.
    Rodriguez AM; Zeybek B; Asoglu MR; Sak ME; Tan A; Borahay MA; Kilic GS
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():31-5. PubMed ID: 26699101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No. 371-Morcellation During Gynaecologic Surgery: Its Uses, Complications, and Risks of Unsuspected Malignancy.
    Murji A; Scott S; Singh SS; Bougie O; Leyland N; Laberge PY; Vilos GA
    J Obstet Gynaecol Can; 2019 Jan; 41(1):116-126. PubMed ID: 30580824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electric morcellation-related reoperations after laparoscopic myomectomy and nonmyomectomy procedures.
    Pereira N; Buchanan TR; Wishall KM; Kim SH; Grias I; Richard SD; Della Badia CR
    J Minim Invasive Gynecol; 2015 Feb; 22(2):163-76. PubMed ID: 25218993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of undiagnosed uterine leiomyosarcoma in women undergoing hysterectomy or myomectomy for benign indications.
    Lange S; Pluchino N; Fehlmann A; Marci R; Boukrid M; Jazia IB; Petignat P; Dubuisson J
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():239-244. PubMed ID: 28743407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Malignancy and Myoma Variants at Surgery for Presumed Benign Symptomatic Myomas.
    Damasco MR; Chan PK; Slonim M; Ang WC; Healey MG
    J Minim Invasive Gynecol; 2017; 24(4):659-664. PubMed ID: 28216458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of unexpected uterine leiomyosarcoma during laparoscopic procedures: Experience from a single tertiary institute in Italy.
    Surace A; Baù MG; Privitera S; Botta G; Danese S; Plazzotta C; Mitidieri M; Picardo E
    Int J Gynaecol Obstet; 2022 Feb; 156(2):236-239. PubMed ID: 33834486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
    Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
    Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult uterine leiomyosarcoma in women undergoing abdominal and minimally invasive surgeries for myomas.
    Ludwin A; Gawron I; Pityński K
    Ginekol Pol; 2018; 89(10):546-552. PubMed ID: 30393842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine Sarcomas in Patients Undergoing Surgery for Presumed Leiomyomas: 10 Years' Experience.
    Paul PG; Rengaraj V; Das T; Garg R; Thomas M; Khurd AS
    J Minim Invasive Gynecol; 2016; 23(3):384-9. PubMed ID: 26677821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonmalignant Sequelae of Unconfined Morcellation at Laparoscopic Hysterectomy or Myomectomy.
    Tulandi T; Leung A; Jan N
    J Minim Invasive Gynecol; 2016; 23(3):331-7. PubMed ID: 26802909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACOG Committee Opinion No. 770 Summary: Uterine Morcellation for Presumed Leiomyomas.
    Obstet Gynecol; 2019 Mar; 133(3):604-605. PubMed ID: 30801469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation.
    Zhang J; Li T; Zhang J; Zhu L; Lang J; Leng J
    Int J Gynecol Cancer; 2016 Mar; 26(3):456-63. PubMed ID: 26807642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Morcellation Techniques at the Time of Laparoscopic Hysterectomy and Myomectomy.
    Meurs EAIM; Brito LG; Ajao MO; Goggins ER; Vitonis AF; Einarsson JI; Cohen SL
    J Minim Invasive Gynecol; 2017; 24(5):843-849. PubMed ID: 28483536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine Morcellation for Presumed Leiomyomas: ACOG Committee Opinion, Number 822.
    Obstet Gynecol; 2021 Mar; 137(3):e63-e74. PubMed ID: 33595252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.